Dr. rer. nat. Thomas Fließwasser

Commissarial Junior Group Leader

Research

Thomas Fließwasser studied biology (B.Sc.) and microbiology (M.Sc.) at the University of Bonn and has specialized on gut bacteria research since his doctorate, where he elucidated the central carbon and energy metabolism of the important human gut bacterium Segatella copri (basonym Prevotella copri).
In 2021 he became a postdoctoral researcher in Fabian Grein’s DZIF research group ‘Bacterial Interference’ at the IPM, during which he co-developed an in vitro gut community model for the evaluation of decolonization strategies against enteropathogens.
Since the departure of his former group leader in April 2024, Thomas Fließwasser has taken over the junior research group as the commissarial group leader.
Avatar Fließwasser

Dr. rer. nat. Thomas Fließwasser

Commissarial Junior Group Leader

+49 228 73-7923

room 0.005

Meckenheimer Allee 168

53115 Bonn

© Thomas Fließwasser

CV

2024/04 - present Commissarial Group Leader | Institute for Pharmaceutical Microbiology, DZIF JRG Bacterial Interference, University Hospital Bonn

2021/01 - present Postdoctoral Researcher | Institute for Pharmaceutical Microbiology, DZIF JRG Bacterial Interference, University Hospital Bonn

2019/10 – 2020/12 Postdoctoral Researcher | Institute for Microbiology and Biotechnology, Department Applied Microbiology and Biotechnology, University of Bonn

2015/10 – 2019/03 Scientific Associate | Institute for Microbiology and Biotechnology, Department Applied Microbiology and Biotechnology, University of Bonn

2013/06 – 2013/08 Student Assistent | Institute of Cellular and Molecular Botany, Department Ecophysiology, University of Bonn

2015/10 – 2020/05 Doctorate (Dr. rer. nat. Biology) | University of Bonn

2013/10 – 2015/09 M.Sc. Microbiology | University of Bonn

2010/10 – 2013/09 B.Sc. Biology | University of Bonn

VAAM (Association for General and Applied Microbiology)

DZIF, TTU HAARBI (German Center for Infection Research, Thematic Translation Unit Hospital Acquired and Antibiotic Resistant Bacterial Infections

DGHT (German Society for Herpetology and Herpetoculture)

Funding

German Center for Infection Research (DZIF), TTU Healthcare-Associated and Antibiotic-Resistant Bacterial Infections (HAARBI)

DZIF FlexFund: EVREA-Phage - Eradication of intestinal VRE Enterococcus faecium by oral phage therapy: preparation of preclinical tests and IMP data for future clinical trial application

Honours and Awards